Derek Wilke
Papers
1
Total Citations
16
H-Index
1
About
Derek Wilke is a radiation oncology researcher whose work focuses on quantifying and minimizing the long-term risks of cancer treatment, particularly secondary malignancies arising from radiotherapy. His most cited study, "Estimation of Annual Secondary Lung Cancer Deaths Using Various Adjuvant Breast Radiotherapy Techniques for Early-Stage Cancers" (2021, 16 citations), addresses a critical clinical dilemma: the life-saving benefits of adjuvant breast radiotherapy can be offset decades later by radiation-induced lung cancers. Wilke’s analysis demonstrated that for early-stage breast cancer patients with favorable prognoses, the risk of secondary lung cancer death becomes a significant concern after 25–30 years. By modeling different radiotherapy techniques, he showed that modern approaches—such as deep inspiration breath-hold or proton therapy—could substantially reduce these fatal secondary cancers. This work has direct implications for treatment planning, especially for younger patients with long life expectancies. Wilke’s research bridges radiation physics, clinical oncology, and long-term survivorship, helping clinicians balance tumor control against iatrogenic harm. His findings underscore the importance of personalized risk assessment in radiotherapy, ensuring that patients not only survive their primary cancer but also avoid preventable deaths from treatment decades later.
Research Focus
Key Achievements
Top Papers
- 1